| Ad Title: |
Endometrial Cancer |
| Study Title: |
GOG-210: A Molecular Staging Study of Endometrial Cancer |
| Protocol Number: |
042005-026 |
| Department(s) involved in the Study: |
Gynecology, Obstetrics & Gynecology, Simmons Comprehensive Cancer Center
|
| Purpose of the Study: |
To collect samples and information from patients who have endometrial cancer. Tissue, urine and serum will be collected from patients with endometrial cancer. Other information will also be collected (age, race, level of education, health history, family history). It is hoped that the information can be used by researchers to learn more about, treat and prevent endometrial cancer. |
| Participant Eligibility: |
1. Patients with endometrial cancer or carcinosarcoma diagnosed by an endometrial biopsy or D&C who will undergo full surgical staging.
2. Patients who have not received prior pelvic or abdominal radiation therapy. |
| Disease/Condition Under Study: |
Endometrial Cancer |
| Cancer Related Study: |
Yes
|
| Study Drug(s): |
|
| Study Device(s): |
|
| Study Doctor: |
Dr. David Miller |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Parkland Memorial Hospital
|
Yes
|
|
Aston Ambulatory Care Center
|
Yes
|
|
| Contact Phone: |
214_648_6753 |
| Email: |
Paula.Honea@utsouthwestern.edu |
| Other Information: |
This is aGynecologic Oncology Group sponsored trial. |
| Website Keywords: |
Gyn Oncology, Gynecology, Women's Health
|
| Medical Keywords: |
cancer
|
